Kuo-Chih Wang Selected Research

Infections

6/2015	Yakammaoto inhibits enterovirus 71 infection by reducing viral attachment, internalization, replication, and translation.
12/2013	Water extract of Pueraria lobata Ohwi has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
1/2012	Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.
5/2011	Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.
5/2011	Expression of avian reovirus minor capsid protein in plants.
7/2004	Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A.
4/2004	Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuo-Chih Wang Research Topics

Disease

7	Infections 06/2015 - 04/2004
3	Virus Diseases (Viral Diseases) 01/2012 - 07/2004
1	Respiratory Syncytial Virus Infections 01/2012
1	Viremia 01/2007

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 01/2012 - 04/2004
2	CytokinesIBA 01/2012 - 05/2011
1	yakammaotoIBA 06/2015
1	InterferonsIBA 12/2013
1	Ribavirin (Virazole)FDA LinkGeneric 12/2013
1	cimicifuginIBA 01/2012
1	EnzymesIBA 01/2012
1	ImmunosorbentsIBA 01/2012
1	sheng-ma-ge-gen-tangIBA 05/2011
1	Complex MixturesIBA 05/2011
1	Codon (Codons)IBA 05/2011
1	Subunit VaccinesIBA 05/2011
1	VaccinesIBA 05/2011
1	Proteins (Proteins, Gene)FDA Link 05/2011
1	NucleotidesIBA 01/2007
1	shosaiko-to (TJ9)IBA 01/2007
1	pterocarnin AIBA 07/2004
1	putranjivain AIBA 04/2004

Therapy/Procedure

1	Therapeutics 01/2012